Abstract
Introduction. The article is of relevance due to the need to develop models of regional development within the diversity of socio-economic, natural and geographical conditions of the constituent entities of the Russian Federation. The purpose of the paper is to review the problems and risks standing in the way of the development and implementation of the up-to-date strategy of regional development as well as to identify the models of development of the constituent entities, based on an analysis of a certain system of factors. Materials and Methods. The methods of factor and systemic analysis of socio-economic, geographical and natural indicators were employed; content analysis was performed and an overview of the strengths and weaknesses of the country’s regions was given. Results. An analysis of socio-economic indicators and of the dynamics of the development of the constituent entities of the Russian Federation has been performed as well as that of their natural and geographical conditions. A typology of regions has been developed, which includes eight classifications taking into account their strengths and weaknesses, geographical location and resources available. The reasons for the lack of an up-to-date model of development of the constituent entities of the Russian Federation and the risks associated with the adoption of this strategy have been identified. Discussion and Conclusion. Due to the rather high difference between the regions in economic, social, natural and geographical conditions, it is necessary to take into account the identified features when devising a regional development strategy. This approach can make the best possible use of the competitive advantages of each of the constituent entities of the Russian Federation; it can help form a competent system of intra-regional relations and reduce the proportion of wrong decisions, measures and policies for regional development.
Highlights
In the context of global competition between intellectual industries and building transnational structures that ensure socio-economic development, joining the world’s top 5 most innovative economies is possible only in case of increasing the science intensity of the business sector of the economy
Based on the results of the study conducted, the article gives an analysis of the industry average values of the costs of enterprises for research and development (R&D) in economically developed countries and outlines proposals for achieving a similar level of costs for such work in Russia
The practice of strategizing Russia’s regions makes it possible to single out the regional dimension as a self-sufficient subject of cognitive modeling
Summary
Ensuring the safety of medicines is the basis for the existence and functioning of any pharmacovigilance system as a type of activity aimed at obtaining and processing information about the undesirable consequences of the use of medicines. Исследование особенностей функционирования систем фармаконадзора в странах – участницах международной программы мониторинга безопасности лекарственных средств позволило выделить несколько типов организации сбора информации о нежелательных реакциях лекарственных средств: централизованный, децентрализованный и смешанный. Такой тип организации системы фармаконадзора представлен, например, в США, где все контролирующие функции в сфере оборота лекарственных средств возложены на Управление по санитарному надзору за качеством пищевых продуктов и медикаментов (Food and Drug Administration, FDA), которое является одним из федеральных исполнительных департаментов Министерства здравоохранения и социальных служб США. Основой функционирования централизованной системы фармаконадзора в США является программа MedWatch, позволяющая специалистам здравоохранения, пациентам и потребителям предоставлять в FDA информацию о нежелательных реакциях, возникающих при применении рецептурных и безрецептурных лекарственных средств, особенностях применения биологических препаратов, специальных пищевых продуктов (например, детских питательных смесей), а также о медицинских приборах и косметологических средствах. The centralized type of organization of the pharmacovigilance system exemplified by the U.S Food and Drug Administration (FDA)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
